Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$15.53
-6.00%
Mkt Cap $871.54M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
Implied Upside
+190.6%
Consensus $45.13 vs current $15.53
NASDAQ·Healthcare·Biotechnology
$15.53
-6.00%
Mkt Cap $871.54M
Buy
10
Hold
0
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
+190.6%
Consensus $45.13 vs current $15.53